metformin has been researched along with Delirium in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Delirium: A disorder characterized by CONFUSION; inattentiveness; disorientation; ILLUSIONS; HALLUCINATIONS; agitation; and in some instances autonomic nervous system overactivity. It may result from toxic/metabolic conditions or structural brain lesions. (From Adams et al., Principles of Neurology, 6th ed, pp411-2)
| Excerpt | Relevance | Reference |
|---|---|---|
| " The relationship between metformin use and delirium, and the relationship between metformin use and 3-year mortality were investigated." | 8.12 | The potential benefit of metformin to reduce delirium risk and mortality: a retrospective cohort study. ( Akers, CC; Anderson, ZE; Chang, G; Cho, HR; Comp, KR; Crutchley, KJ; Iwata, M; Jellison, SS; Lee, S; Marra, PS; Meyer, AA; Modukuri, M; Shinozaki, E; Shinozaki, G; Sullivan, EJ; Tran, T; Wahba, NE; Yamanashi, T, 2022) |
| " The relationship between metformin use and delirium, and the relationship between metformin use and 3-year mortality were investigated." | 4.12 | The potential benefit of metformin to reduce delirium risk and mortality: a retrospective cohort study. ( Akers, CC; Anderson, ZE; Chang, G; Cho, HR; Comp, KR; Crutchley, KJ; Iwata, M; Jellison, SS; Lee, S; Marra, PS; Meyer, AA; Modukuri, M; Shinozaki, E; Shinozaki, G; Sullivan, EJ; Tran, T; Wahba, NE; Yamanashi, T, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yamanashi, T | 3 |
| Anderson, ZE | 3 |
| Modukuri, M | 3 |
| Chang, G | 3 |
| Tran, T | 3 |
| Marra, PS | 3 |
| Wahba, NE | 3 |
| Crutchley, KJ | 3 |
| Sullivan, EJ | 3 |
| Jellison, SS | 3 |
| Comp, KR | 3 |
| Akers, CC | 3 |
| Meyer, AA | 3 |
| Lee, S | 3 |
| Iwata, M | 3 |
| Cho, HR | 3 |
| Shinozaki, E | 3 |
| Shinozaki, G | 3 |
1 other study available for metformin and Delirium
| Article | Year |
|---|---|
The potential benefit of metformin to reduce delirium risk and mortality: a retrospective cohort study.
Topics: Delirium; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Metformin; Retrospective Studies; | 2022 |
The potential benefit of metformin to reduce delirium risk and mortality: a retrospective cohort study.
Topics: Delirium; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Metformin; Retrospective Studies; | 2022 |
The potential benefit of metformin to reduce delirium risk and mortality: a retrospective cohort study.
Topics: Delirium; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Metformin; Retrospective Studies; | 2022 |
The potential benefit of metformin to reduce delirium risk and mortality: a retrospective cohort study.
Topics: Delirium; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Metformin; Retrospective Studies; | 2022 |
The potential benefit of metformin to reduce delirium risk and mortality: a retrospective cohort study.
Topics: Delirium; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Metformin; Retrospective Studies; | 2022 |
The potential benefit of metformin to reduce delirium risk and mortality: a retrospective cohort study.
Topics: Delirium; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Metformin; Retrospective Studies; | 2022 |
The potential benefit of metformin to reduce delirium risk and mortality: a retrospective cohort study.
Topics: Delirium; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Metformin; Retrospective Studies; | 2022 |
The potential benefit of metformin to reduce delirium risk and mortality: a retrospective cohort study.
Topics: Delirium; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Metformin; Retrospective Studies; | 2022 |
The potential benefit of metformin to reduce delirium risk and mortality: a retrospective cohort study.
Topics: Delirium; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Metformin; Retrospective Studies; | 2022 |